Actinium Pharmaceuticals Story Overview

ATNM -- USA Stock  

USD 0.73  0.005  0.69%

Macroaxis does not monitor all media channels or aggregates social signals for Actinium Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Actinium Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Actinium Pharmaceuticals. Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance.
Acquisition or disposition of Actinium Pharmaceuticals securities by Nitya Ray
Filed transaction by Actinium Pharmaceuticals officer. Acquisition or disposition under rule 16b-3

Actinium Pharmaceuticals Inc insider trading alert for acquisition or disposition of series b warrants by Nitya Ray, Executive VP, on March 8, 2018. This event was filed by Actinium Pharmaceuticals with SEC on 2018-03-08. Statement of changes in beneficial ownership - SEC Form 4. Nitya Ray is currently serves as executive vice president head - product development, manufacturing and supply chain of Actinium Pharmaceuticals

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 0.02% . The overall trading delta when the story was published against the current closing price is 73.91% .

Similar stores for Actinium Pharmaceuticals

Actinium Pharmaceuticals, Inc. Stock with Actionnews
Talk Traders Full coverage
Roth Capital Reaffirms Their Buy Rating on Stemline Therapeutics Incnews
Analyst RatingsFull coverage
over two weeks ago at http://www.thestreetpoint.com 
Essential Things For Actinium Pharmaceuticals, Inc. , CAE Inc. , Medley Management Inc ...
Thestreet News
The Stock Street Full coverage
over two weeks ago at http://finbulletin.com 
Rising above circumstances Actinium Pharmaceuticals, Inc. , Apartment Investment and Management ...
news
FinBulletinFull coverage
over a month ago at http://www.journalfinance.net 
Alarming Stocks Ocean Power Technologies, Inc. , Actinium Pharmaceuticals, Inc. NYSEATNM ...
news
Market Breaking Point Full coverage
Dont Forget to Observe This Stock Actinium Pharmaceuticals, Inc.news
News Stays On Track Evaluate Analysts Opinions Actinium Pharmaceuticals, Inc. Talk Traders Full coverage
over a month ago at http://www.thestreetpoint.com 
Most Strategic Ways To Accelerate Your Investment- Actinium Pharmaceuticals, Inc. , VBI Vaccines Inc ...
Thestreet News
The Stock Street Full coverage
over a month ago at http://enbulletin.com 
Analysts See -0.06 EPS for Actinium Pharmaceuticals, Inc. McDermott International, Inc. Covered By 2 ...
news
The EN BulletinFull coverage
over a month ago at http://nysedaily.com 
Hot Aspects to Watch Out Actinium Pharmaceuticals, Inc.
news
NYSE DAILY Full coverage
over two months ago at http://cardinalweekly.com 
EPS for Actinium Pharmaceuticals, Inc. Expected At -0.06 Spectrum Capital Trust I Has 1.36 Sentiment
news
The Cardinal Weekly Full coverage
over two months ago at http://globalexportlines.com 
Worth Watching Traders Buzzers Actinium Pharmaceuticals, Inc., , Precision Drilling Corporation ...
news
Global Export Lines Full coverage
over three months ago at http://www.journalfinance.net 
Hot Stocks to Observe Actinium Pharmaceuticals, Inc. , Compugen Ltd. , Centrus ...
news
Market Breaking Point Full coverage
over three months ago at http://www.nasdaqfortune.com 
Actinium Pharmaceuticals, Inc. - Profitability Ratios under Consideration
nasdaq News
Nasdaq Fortune Full coverage

Return On Asset

Return On Asset Comparative Analysis

  Return On Asset 
      Actinium Pharmaceuticals Comparables 
Actinium Pharmaceuticals is currently under evaluation in return on asset category among related companies. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Peers

Actinium Pharmaceuticals Related Equities

DMPI  4.88 %   
0%
100.0%
EDGE  3.50 %   
0%
71.0%
DNLI  2.25 %   
0%
46.0%
ECYT  2.11 %   
0%
43.0%
DRNA  1.78 %   
0%
36.0%
NK  1.64 %   
0%
33.0%
CO  0.31 %   
0%
6.0%
DOVA  0.49 %   
9.0%
0%
EARS  1.39 %   
28.0%
0%
DVAX  1.64 %   
33.0%
0%
Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.
Search macroaxis.com